Wikidata

(Q63393866)

English

A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)

clinical trial

In more languages

Statements

title
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of RO6867461 in Patients With Diabetic Macular Edema (YOSEMITE) (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Austria
0 references
Bulgaria
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Peru
0 references
Poland
0 references
Slovakia
0 references
Spain
0 references
Turkey
0 references
start time
5 September 2018
0 references
end time
30 September 2021
0 references
number of participants
900
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63393866&oldid=1857188689"